Targeted delivery of bone growth factors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2102808

2102808 9220371 PCTABS00017 Methods and compositions for using conjugates of bone growth factors and targeting molecules in bone repair and augmentation are provided. The bone growth factor and targeting molecule are chemically conjugated to a crosslinker. The crosslinker is preferably a synthetic hydrophilic polymer. The bone growth factor is preferably TGF-.beta., activin, or bone morphogenic protein (BMP). Targeting molecules preferably have an affinity for bone, such as tetracycline, calcein, bisphosphonate, polyaspartic acid, polyglutamic acid, aminophosphosugars, or estrogen.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Targeted delivery of bone growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeted delivery of bone growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted delivery of bone growth factors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1953400

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.